Search Results for: carcinoid syndrome

NET Fusion Live Educational Awareness Program on Facebook

A Facebook live online version of NET Fusion, a new educational disease awareness program from Novartis designed to help people with carcinoid syndrome better understand the science of food, will take place on Wednesday, November 16 from 7:00 to 7:30…

Lexicon Pharmaceuticals Submits New Drug Application for Telotristat Etiprate

Lexicon Pharmaceuticals has submitted a new drug application to the US Food and Drug Administration (FDA) for Telotristat Etiprate for the treatment of carcinoid syndrome.

For patients with carcinoid syndrome who are no longer responding to the current…

Neuroendocrine Tumors to Be Focus of Presentations and Posters at ASCO Gastrointestinal Cancers Symposium

Presentations on recent advances in the treatment of neuroendocrine tumors (NETs) and new findings from the NETTER-1 clinical study on PRRT with Lutathera along with posters on a wide variety of subjects about NETs will be part of the program during the…

Neuroendocrine Tumors to Be Focus of February 2016 Issue of Hematology/Oncology Clinics

Neuroendocrine Tumors Focus of Upcoming Issue of Hematology/Oncology Clinics

Neuroendocrine Tumors will be featured in the February 2016 issue of Hematology/Oncology Clinics. Dr. Jennifer Chan and Dr. Matthew Kulke, both from Dana-Farber Cancer Institute in Boston, Massachusetts are Editors of the issue, published by Elsevier.…

Treatment Options

Shah GM, Shah RG, Veillette…

Combination Therapy with Octreotide and Alpha-interferon

A very important clinical research report  is published in the May issue of The American Journal of Gastroenterology  (Margaret Frank et.al. Combination Therapy with Octreotide and alpha-interferon:effect on tumor growth in metstatic endocrine…

Preparing for the 24-Hour Urine 5HIAA Test

The old saying, “We are what we eat,” applies when a 24-hour collection for the urine 5HIAA test is being considered. The foods that contain the precursor of 5HIAA should be avoided for at least 24 …

Understanding the Biochemical Markers

Presented by
Nancy Gardner, Ph.D., ARNP
GI Tumor Program
H. Lee Moffitt Cancer Center and Research Institute,
Tampa, FL

Carcinoid Symposium Spring 2002
Tampa, Florida
April 12, 2002

When a patient is diagnosed with carcinoid they begin hearing a lot …

Peptides and Amines: What Are They and What Do They Do?

Presented by:
Thomas M. O’Dorisio, M.D.
Professor: Department of Internal Medicine,
Division of Endocrinology and Metabolism
University of Iowa

Transcript of lecture from the
CARCINOID TREATMENT TODAY AND TOMORROW
(for Carcinoid Patients,…